Tag: Innovations in Clinical Neuroscience

Editor’s Message: September–October 2016 Issue Highlights

Editor’s Message: September–October 2016 Issue Highlights

| October 9, 2016 | 0 Comments

Dear Colleagues: Welcome to the September-October 2016 issue of Innovations in Clinical Neuroscience (ICNS). As the official journal of the CNS Summit, the International Society for CNS Drug Development (ISCDD), and the International Society for CNS Clinical Trials and Methodology (ISCTM), an important part of our editorial mission is to accelerate and enhance the development […]

Continue Reading

Editor’s Message—Issue Highlights, July–August 2016

Editor’s Message—Issue Highlights, July–August 2016

| August 1, 2016 | 0 Comments

Dear Colleagues: Welcome to the July–August 2016 issue of Innovations in Clinical Neuroscience. We start this issue with an interesting study by MacEwan et al titled, “Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases.” Here, the authors assessed the level of private and public investment in research and development […]

Continue Reading

Editor’s Message and May–June 2016 Issue Highlights

Editor’s Message and May–June 2016 Issue Highlights

| June 1, 2016 | 0 Comments

Dear Colleagues: Welcome to the May–June 2016 issue of Innovations in Clinical Neuroscience. I am pleased to start the issue with the first of a series of articles we’ll be publishing that will explore the emerging field of digital medicine and how innovative technology can improve patient outcomes in the field of neuroscience. I am […]

Continue Reading

Editor’s Message and Issue Highlights

Editor’s Message and Issue Highlights

| April 1, 2016 | 0 Comments

Dear Colleagues: Welcome to the March–April 2016 issue of Innovations in Clinical Neuroscience (ICNS). Attitudes regarding marijuana use have changed dramatically over the past 50-plus years in the United States. According to data from the Pew Research Center, support for the legalization of marijuana has gone from 12 percent of the American population in favor […]

Continue Reading

Editor’s Message and Issue Highlights, September–October 2015

Editor’s Message and Issue Highlights, September–October 2015

| October 10, 2015 | 0 Comments

Dear Colleagues: Welcome to the September–October 2015 issue of Innovations in Clinical Neuroscience. We start this issue with an intriguing review by Yarlagadda et al titled,“Placental Barrier and Autism Spectrum Disorders: The Role of Prolactin and Dopamine on the Developing Fetal Brain.” Here the authors explore a possible link between in-utero exposure to a high […]

Continue Reading

Editor’s Message and Issue Highlights—July–August 2015

Editor’s Message and Issue Highlights—July–August 2015

| August 13, 2015 | 0 Comments

Dear Colleagues: Welcome to the July–August 2015 issue of Innovations in Clinical Neuroscience. We begin this issue with a review article by Cole et al titled, “Efficacy of Transcranial Magnetic Stimulation (TMS) in the Treatment of Schizophrenia: A Review of the Literature to Date.” Here the authors examined the literature regarding TMS efficacy in relieving […]

Continue Reading

Editor’s Message and Issue Highlights: May-June 2015

Editor’s Message and Issue Highlights: May-June 2015

| June 11, 2015 | 0 Comments

Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Neuroscience. First, I would like to call your attention to the accompanying supplement to this issue of the journal, a compendium of abstracts from the 2014 CNS Summit poster presentations. Each year, the CNS Summit brings together drug development leaders from pharma, research sites, […]

Continue Reading

Editor’s Message and Issue Highlights—March–April 2015

Editor’s Message and Issue Highlights—March–April 2015

| April 23, 2015 | 0 Comments

Dear Colleagues: Welcome to the March–April 2015 issue of Innovations in Clinical Neuroscience (ICNS). First, I would like to call to your attention the supplement that accompanies this issue of ICNS, presented by the International Society for CNS Clinical Trials and Methodology (ISCTM), of which ICNS is the official publication.

Continue Reading